Abstract
Diagnosis and classification are two essential points for correct patient management. Correct classification allows proper treatment and alerts of the risk of leprosy reaction and nerve damage. The Ridley–Jopling classification recognizes the complex pathogenesis of leprosy and is based on a spectrum that extends from tuberculoid leprosy (TT), through borderline tuberculoid (BT), mid-borderline (BB), borderline lepromatous (BL), to the poorly resistant lepromatous leprosy (LL). The World Health Organization (WHO) classification, for therapeutic purposes, divides patients into paucibacillary (PB) and multibacillary (MB) on the basis of the number of skin lesions. PB cases have up to five skin lesions in total, whereas MB cases have six or more skin lesions. The two systems are complementary rather than exclusive.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ridley DS (1988) Pathogenesis of leprosy and related diseases. Wright, London, Boston, Singapore, Sydney, Toronto, Wellington
Ridley DS, Jopling WH (1962) A classification of leprosy for research purposes. Lepr Rev 33:119–128
Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity—a five-group system. Int J Lepr Other Mycobact Dis 34:255–273
Ridley DS (1988) Nature of the leprosy spectrum. In: Ridley DS (ed) Pathogenesis of leprosy and related diseases. Wright, London, Boston, Singapore, Sydney, Toronto, Wellington, pp 93–105
Noto S, Clapasson A, Nunzi E (2007) Classification of leprosy: the mistery of “reactional tuberculoid”. G Ital Dermatol Venereal 142:294–295
WHO (1982) Chemotherapy of leprosy for control programmes. Technical report series 675. World Health Organization, Geneva
WHO (1988) A guide to leprosy control, 2nd edn. Geneva
WHO (2009) Enhanced global strategy for further reducing the disease burden due to leprosy (2011–2015). Operational Guidelines (Updated)
Guia para o controle da hanseniase (2002) Brasilia DF Ministério da Saúde. http://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf
Talhari S (1996) Diagnosis, classification and prognosis. Int J Lepr 64(suppl):s13–s14
Parkash O (2009) Classification of leprosy into multibacillary and paucibacillary groups: an analysis. FEMS Immunol Med Microbiol 55:1–5
Buhrer-Sekula S, Visschedijk J, Grossi MAF et al (2007) The ML Flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Lepr Rev 78:271–279
Lockwood DN, Sarno E, Smith WC (2007) Classifying leprosy patients–searching for the perfect solution? Lepr Rev 78:317–320
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Massone, C., Brunasso, A.M.G. (2012). Classification. In: Nunzi, E., Massone, C. (eds) Leprosy. Springer, Milano. https://doi.org/10.1007/978-88-470-2376-5_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-2376-5_6
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2375-8
Online ISBN: 978-88-470-2376-5
eBook Packages: MedicineMedicine (R0)